Ligne de temps
Mathieu Mateo
Chargé(e) de Recherche Expert
12 sept. 2023
publication
Hemostasis defects underlying the hemorrhagic syndrome caused by Mammarenaviruses in a cynomolgus macaque model.
Lire plus11 mars 2023
publication
Rapid protection induced by a single-shot Lassa vaccine in male cynomolgus monkeys
Lire plus01 janv. 2023
publication
A MOPEVAC multivalent vaccine induces sterile protection against New World arenaviruses in non-human primates.
Lire plus01 déc. 2022
publication
Pathogenesis of recent Lassa virus isolates from lineages II and VII in cynomolgus monkeys.
Lire plus09 juin 2021
publication
A single-shot Lassa vaccine induces long-term immunity and protects cynomolgus monkeys against heterologous strains.
Lire plus04 janv. 2021
publication
Systemic viral spreading and defective host responses are associated with fatal Lassa fever in macaques.
Lire plus01 déc. 2020
publication
Lassa fever in Benin: description of the 2014 and 2016 epidemics and genetic characterization of a new Lassa virus.
Lire plus01 mai 2020
publication
Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical Trials.
Lire plus03 janv. 2020
01 déc. 2019
publication
A 40-Month Follow-Up of Ebola Virus Disease Survivors in Guinea (PostEbogui) Reveals Long-Term Detection of Ebola Viral Ribonucleic Acid in Semen and Breast Milk.
Lire plus02 oct. 2019
publication
Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot.
Lire plus01 sept. 2019
23 mars 2019
21 mars 2019
publication
Non-Pathogenic Mopeia Virus Induces More Robust Activation of Plasmacytoid Dendritic Cells than Lassa Virus
Lire plus10 janv. 2019
01 nov. 2018
publication
Lassa virus activates myeloid dendritic cells but suppresses their ability to stimulate T cells.
Lire plus01 oct. 2018
publication
Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies
Lire plus29 mai 2018
publication
A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins
Lire plus28 sept. 2017
publication
Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs
Lire plus15 juin 2017
publication
Dynamics of Ebola RNA Persistence in Semen: A Report From the Postebogui Cohort in Guinea
Lire plus23 mars 2017
publication
Clinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, Guinea
Lire plus23 févr. 2017
publication
Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted
Lire plus14 janv. 2017
publication
Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study
Lire plus18 déc. 2016
14 nov. 2016
03 mai 2016
publication
New Evidence of Long-lasting Persistence of Ebola Virus Genetic Material in Semen of Survivors
Lire plus05 avr. 2016
publication
Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
Lire plus01 mars 2016
publication
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
Lire plus07 janv. 2016
16 déc. 2015
21 juil. 2015
publication
Severe Ebola Virus Infection With Encephalopathy: Evidence for Direct Virus Involvement
Lire plus19 juil. 2015
03 juil. 2015
11 mai 2015
06 févr. 2015
publication
Ebola virus in West Africa: new conquered territories and new risks-or how I learned to stop worrying and (not) love Ebola virus
Lire plus01 janv. 2015
publication
Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014
Lire plus24 nov. 2014
publication
Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014
Lire plus19 nov. 2014
24 sept. 2014
publication
Exonuclease domain of the Lassa virus nucleoprotein is critical to avoid RIG-I signaling and to inhibit the innate immune response
Lire plus24 sept. 2014
publication
The exonuclease domain of Lassa virus nucleoprotein is involved in antigen-presenting-cell-mediated NK cell responses
Lire plus16 avr. 2014
09 janv. 2014
publication
Production of CXC and CC chemokines by human antigen-presenting cells in response to Lassa virus or closely related immunogenic viruses, and in cynomolgus monkeys with lassa fever
Lire plus05 nov. 2012
01 juil. 2012
publication
NK cells are strongly activated by Lassa and Mopeia virus-infected human macrophages in vitro but do not mediate virus suppression
Lire plus31 août 2011
publication
Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages
Lire plus01 juin 2011
publication
Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus
Lire plus09 févr. 2011
05 oct. 2010
publication
Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis
Lire plus01 oct. 2010
18 mars 2009
publication
Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys
Lire plus20 mars 2006
publication
Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages
Lire plus01 juil. 2005
01 oct. 2004
publication
Human macrophages, but not dendritic cells, are activated and produce alpha/beta interferons in response to Mopeia virus infection
Lire plus01 mars 2004
publication
Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells
Lire plus01 déc. 2003